Related Experiment Video
Updated: Jul 5, 2026
High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
Published on: January 22, 2019
p14ARF is capable of promoting HIV-1 tat degradation
Barbara Gargano1, Marianna Fiorillo, Stefano Amente
1Department of Structural and Functional Biology, University of Naples Federico II, Naples, Italy.
Abstract:
The p14(ARF) tumor suppressor functions as 'oncogenic checkpoint' that prevents unrestricted cellular proliferation in response to oncogenic signaling. Albeit, the major pathway through which ARF operates is the ARF-Mdm2-p53 axis, ARF directly binds to and inactivates transcription function of a number of DNA-bound activators. In the present study we show that p14(ARF) inhibits transcription activation of HIV-1 LTR promoter activity by Tat protein. Tat protein is a RNA-bound transcriptional activator whose function is strictly required for HIV-1 replication. We determined that p14(ARF) inhibits Tat transactivation of HIV-1 LTR by promoting Tat degradation via an ubiquitin-independent pathway.
Insights
The p14(ARF) tumor suppressor inhibits HIV-1 replication by blocking Tat protein activity. This occurs through promoting Tat protein degradation, offering a new target for antiviral therapies.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- p14(ARF) acts as an oncogenic checkpoint, preventing uncontrolled cell growth.
- While the ARF-Mdm2-p53 pathway is primary, ARF also directly inhibits DNA-bound activators.
- HIV-1 replication depends on the Tat protein, a critical RNA-bound transcriptional activator.
Purpose of the Study:
- To investigate the effect of p14(ARF) on HIV-1 Long Terminal Repeat (LTR) promoter activity mediated by Tat.
- To elucidate the mechanism by which p14(ARF) influences Tat protein function.
Main Methods:
- Assessing the impact of p14(ARF) on Tat-driven HIV-1 LTR promoter activity.
- Investigating the effect of p14(ARF) on Tat protein stability and degradation pathways.
Main Results:
- p14(ARF) was found to inhibit Tat-mediated transcription activation of the HIV-1 LTR promoter.
- The study demonstrated that p14(ARF) promotes the degradation of Tat protein.
- This degradation was determined to occur via an ubiquitin-independent pathway.
Conclusions:
- p14(ARF) directly interferes with a key step in HIV-1 replication by targeting the Tat protein.
- The mechanism involves promoting Tat degradation through a non-ubiquitin-dependent route.
- These findings suggest p14(ARF) as a potential target for novel anti-HIV therapies.
